Newsroom
STAY INFORMED
Recent News
Johns Hopkins Treats First Patient in the United States as Part of Imricor’s VISABL-AFL Clinical Trial
August 14, 2024VISABL-AFL Trial for US FDA Approval Commences at Cardiovascular Institute of South Paris
June 21, 2024Imricor Receives Approval from Saudi Food and Drug Authority
January 17, 2024Imricor Expands Middle East Footprint Into Qatar
December 21, 2023See All News →
Upcoming Events
There are no upcoming events currently.